Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy
- PMID: 38168935
- DOI: 10.1038/s43018-023-00672-2
Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy
Abstract
Onco-fetal reprogramming of the tumor ecosystem induces fetal developmental signatures in the tumor microenvironment, leading to immunosuppressive features. Here, we employed single-cell RNA sequencing, spatial transcriptomics and bulk RNA sequencing to delineate specific cell subsets involved in hepatocellular carcinoma (HCC) relapse and response to immunotherapy. We identified POSTN+ extracellular matrix cancer-associated fibroblasts (EM CAFs) as a prominent onco-fetal interacting hub, promoting tumor progression. Cell-cell communication and spatial transcriptomics analysis revealed crosstalk and co-localization of onco-fetal cells, including POSTN+ CAFs, FOLR2+ macrophages and PLVAP+ endothelial cells. Further analyses suggest an association between onco-fetal reprogramming and epithelial-mesenchymal transition (EMT), tumor cell proliferation and recruitment of Treg cells, ultimately influencing early relapse and response to immunotherapy. In summary, our study identifies POSTN+ CAFs as part of the HCC onco-fetal niche and highlights its potential influence in EMT, relapse and immunotherapy response, paving the way for the use of onco-fetal signatures for therapeutic stratification.
© 2024. The Author(s), under exclusive licence to Springer Nature America, Inc.
Similar articles
-
Onco-fetal Reprogramming of Endothelial Cells Drives Immunosuppressive Macrophages in Hepatocellular Carcinoma.Cell. 2020 Oct 15;183(2):377-394.e21. doi: 10.1016/j.cell.2020.08.040. Epub 2020 Sep 24. Cell. 2020. PMID: 32976798
-
POSTN+ cancer-associated fibroblasts determine the efficacy of immunotherapy in hepatocellular carcinoma.J Immunother Cancer. 2024 Jul 27;12(7):e008721. doi: 10.1136/jitc-2023-008721. J Immunother Cancer. 2024. PMID: 39067872 Free PMC article.
-
A new perspective on the immune escape mechanism in HCC: onco-foetal reprogramming.Br J Cancer. 2021 Jun;124(12):1897-1899. doi: 10.1038/s41416-021-01286-0. Epub 2021 Mar 25. Br J Cancer. 2021. PMID: 33767421 Free PMC article.
-
Immunosuppressive mechanisms of oncofetal reprogramming in the tumor microenvironment: implications in immunotherapy response.Biochem Soc Trans. 2023 Apr 26;51(2):597-612. doi: 10.1042/BST20220157. Biochem Soc Trans. 2023. PMID: 36938978 Free PMC article. Review.
-
Cancer-associated fibroblasts in hepatocellular carcinoma.World J Gastroenterol. 2016 Aug 14;22(30):6841-50. doi: 10.3748/wjg.v22.i30.6841. World J Gastroenterol. 2016. PMID: 27570421 Free PMC article. Review.
Cited by
-
Opposing regulation of the STING pathway in hepatic stellate cells by NBR1 and p62 determines the progression of hepatocellular carcinoma.Mol Cell. 2024 Dec 5;84(23):4660-4676.e10. doi: 10.1016/j.molcel.2024.09.026. Epub 2024 Oct 17. Mol Cell. 2024. PMID: 39423823
-
[Endothelial cells and fibroblasts mediate the microenvironmental regulatory network of carotid body paraganglioma].Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024 Sep;38(9):788-796. doi: 10.13201/j.issn.2096-7993.2024.09.003. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024. PMID: 39193734 Free PMC article. Chinese.
-
Spatial landscapes of cancers: insights and opportunities.Nat Rev Clin Oncol. 2024 Sep;21(9):660-674. doi: 10.1038/s41571-024-00926-7. Epub 2024 Jul 23. Nat Rev Clin Oncol. 2024. PMID: 39043872 Review.
-
Sophisticated roles of tumor microenvironment in resistance to immune checkpoint blockade therapy in hepatocellular carcinoma.Cancer Drug Resist. 2025 Feb 26;8:10. doi: 10.20517/cdr.2024.165. eCollection 2025. Cancer Drug Resist. 2025. PMID: 40051497 Free PMC article. Review.
-
Periostin-mediated activation of NF-κB signaling promotes tumor progression and chemoresistance in glioblastoma.Sci Rep. 2025 Apr 22;15(1):13955. doi: 10.1038/s41598-025-92969-8. Sci Rep. 2025. PMID: 40263417 Free PMC article.
References
MeSH terms
Substances
Grants and funding
- NRF2016NRF-NRFI001-02/National Research FoundationSingapore (National Research Foundation-Prime Minister's office, Republic of Singapore)
- 2021/GNT2010795/Department of Health | National Health and Medical Research Council (NHMRC)
- 2022/MRF2016215/Department of Health | National Health and Medical Research Council (NHMRC)
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous